A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy

Abstract

Tau inclusions are a shared feature of many neurodegenerative diseases, among them frontotemporal dementia caused by tau mutations. Treatment approaches for these conditions include targeting posttranslational modifications of tau proteins, maintaining a steady-state amount of tau, and preventing its tendency to aggregate. We discovered a new regulatory pathway for tau degradation that operates through the farnesylated protein, Rhes, a GTPase in the Ras family. Here, we show that treatment with the farnesyltransferase inhibitor lonafarnib reduced Rhes and decreased brain atrophy, tau inclusions, tau sumoylation, and tau ubiquitination in the rTg4510 mouse model of tauopathy. In addition, lonafarnib treatment attenuated behavioral abnormalities in rTg4510 mice and reduced microgliosis in mouse brain. Direct reduction of Rhes in the rTg4510 mouse by siRNA reproduced the results observed with lonafarnib treatment. The mechanism of lonafarnib action mediated by Rhes to reduce tau pathology was shown to operate through activation of lysosomes. We finally showed in mouse brain and in human induced pluripotent stem cell–derived neurons a normal developmental increase in Rhes that was initially suppressed by tau mutations. The known safety of lonafarnib revealed in human clinical trials for cancer suggests that this drug could be repurposed for treating tauopathies.

Rhes Tunnels: A Radical New Way of Communication in the Brain's Striatum?

“…[ 94–96 ] Rhes also plays a critical role in mutant tau‐mediated toxicity. [ 97 ] In addition, a rare, highly conserved de novo mutation (R57H) in Rhes was detected in twins diagnosed on the autism spectrum. [ 98 ] These studies illustrate significant and multifarious roles of Rhes in neuronal functions and neurological diseases.…”

Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome

“…Similar to previous studies, high-content microscopy was performed as reported by Hernandez et al 41 . Cells plated in glass-bottom 96-well plates were treated for the indicated times and, after fixation with 4% paraformaldehyde, images were acquired using a high-content microscope (Operetta, Perkin-Elmer).…”

“…4a). Next, we directly analyzed the effect of DSF in macroautophagy, the best characterized type of autophagy, using high-content microscopy in cells expressing a tandem mCherry-GFP-LC3 reporter 41 (Fig. 4b-d).…”

“…Puncta positive for both fluorophores correspond to APGs, whereas those only positive for the red fluorophore correspond to AUTs. Autophagic flux was determined as the conversion of APGs (yellow) to AUTs (red only puncta) 41 .…”

Machine Learning Identifies Novel Candidates for Drug Repurposing in Alzheimer’s Disease

“…NEK6 phosphorylates p70-S6 56 , a key player in hyperphosphorylation of Tau 57,58 that leads to microtubule disruption and deposition of Tau tangles. It was found to be relevant to the progression of AD and proposed as an early diagnostic biomarker 59,60 NEK9 was found to be differentially expressed in a tauopathy mouse model 61 .…”